— Know what they know.
Not Investment Advice

PAHC NASDAQ

Phibro Animal Health Corporation
1W: -7.4% 1M: -38.0% 3M: -36.5% YTD: -10.1% 1Y: +40.5% 3Y: +161.2% 5Y: +37.6%
$33.26
-0.20 (-0.60%)
 
Weekly Expected Move ±15.0%
$24 $29 $34 $40 $45
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 37 · $1.3B mcap · 40M float · 0.852% daily turnover · Short 46% of daily vol

Cash Flow Trends

Operating Cash Flow
$80M -8.5% ▼
5Y CAGR: +6.2%
Capital Expenditures
$38M +7.1% ▲
5Y CAGR: +2.4%
Free Cash Flow
$42M -9.8% ▼
5Y CAGR: +10.6%
Dividends Paid
$19M -0.0% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$3M -108.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$54M$49M$33M$2M$48M
Depreciation & Amort.$32M$33M$34M$36M$46M
Stock-Based Comp.$1M$0$0$475K$717K
Change in Working Capital-$30M-$45M-$41M$33M-$22M
Other Non-Cash Items-$7M-$5M-$9M$23M$12M
Operating Cash Flow$48M$32M$13M$88M$80M
— Investing Activities —
Capital Expenditures-$29M-$37M-$52M-$41M-$38M
Acquisitions (Net)$29M-$14M$0-$3M-$287M
Investment Purchases-$74M-$64M-$40M-$66M-$14M
Investment Sales$86M$91M$17M$62M$49M
Other Investing-$31M$620K$776K$326K$1M
Investing Cash Flow-$19M-$23M-$74M-$48M-$289M
— Financing Activities —
Net Debt Issuance$5M$41M$43M$13M$236M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$19M-$19M-$19M-$19M-$19M
Other Financing-$3M-$5M$4M-$31K-$9M
Financing Cash Flow-$17M$16M$27M-$7M$207M
Net Change in Cash$14M$24M-$33M$29M-$3M
Cash End of Period$50M$74M$41M$71M$68M
Free Cash Flow$19M-$5M-$38M$46M$42M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms